Steris insider trading
Every open-market purchase and sale by Steris's officers, directors and largest shareholders since November 4, 2021, and what the share price did next.
| Date | Insider | Trade | Shares | Price | Value | 1M after | 3M after | 6M after |
|---|
Does following Steris’s insiders pay?
From May 16, 2019 to August 12, 2026, 17 insiders reported 0 open-market purchases and 65 sales not made under a pre-set plan in Steris. After sales, the shares moved −6.4% against the index over 12 months (a negative figure means selling was the right call).
| Insider | Role | Purchases | 12 months after their purchases | Beat the S&P 500 | Sales | 12 months after their sales | Latest report |
|---|---|---|---|---|---|---|---|
| Majors Cary L | SVP and President, Healthcare | 0 | — | — | 11 | −7.9% (11) | May 22, 2025 |
| Feldmann Cynthia L | Director | 0 | — | — | 7 | −6.9% (6) | March 6, 2026 |
| Sohi Mohsen | Director | 0 | — | — | 7 | −10.6% (6) | August 12, 2026 |
| Kosecoff Jacqueline B | Director | 0 | — | — | 6 | +0.4% (6) | May 15, 2024 |
| Rosebrough Walter M Jr | President & CEO | 0 | — | — | 5 | −8.5% (5) | November 10, 2020 |
| Steeves Richard Martin | Director | 0 | — | — | 5 | +3.9% (5) | December 6, 2019 |
| Tamaro Renato | V.P. & Corporate Treasurer | 0 | — | — | 5 | −9.8% (4) | November 20, 2025 |
| Breeden Richard C | Director | 0 | — | — | 4 | −8.3% (3) | June 4, 2026 |
| Burton Karen L | VP & CAO | 0 | — | — | 4 | −12.8% (4) | August 12, 2025 |
| Madsen Julia | Sr. VP and GM, Life Sciences | 0 | — | — | 3 | −6.7% (2) | November 25, 2025 |
| Lewis David B | Director | 0 | — | — | 2 | −9.8% (2) | December 2, 2020 |
| Carestio Daniel A | Sr VP and Chief Operating Off | 0 | — | — | 1 | −15.2% (1) | August 8, 2019 |
| Holland Christopher S | Director | 0 | — | — | 1 | −14.1% (1) | August 12, 2024 |
| Tokich Michael J | Sr. Vice Pres., CFO | 0 | — | — | 1 | −5.6% (1) | May 17, 2024 |
| Wilson Loyal W | Director | 0 | — | — | 1 | +6.2% (1) | June 5, 2019 |
| Wood Michael B | Director | 0 | — | — | 1 | +13.2% (1) | May 17, 2019 |
| Zangerle John Adam | Sr. VP, Gen Counsel, and Sec. | 0 | — | — | 1 | — | November 13, 2025 |
When several insiders traded Steris
Months when 2 or more insiders became net buyers, or 3 or more net sellers, of Steris in reports dated in the 91 days before the month end, and how the stock did against the S&P 500 from that month end. After 7 selling crowds, −9.2%. One company's history is too short to judge by; the test across every company is the better guide.
| Month | Crowd | 3 months on, vs S&P 500 | 6 months | 12 months |
|---|---|---|---|---|
| August 29, 2025 | 4 selling | +2.7% | −6.3% | −24.9% |
| May 31, 2024 | 7 selling | +1.2% | −16.0% | −4.7% |
| May 31, 2023 | 5 selling | +7.9% | −10.1% | −15.5% |
| February 28, 2022 | 3 selling | +2.5% | −10.0% | −12.6% |
| August 31, 2020 | 3 selling | +17.6% | −2.1% | +4.3% |
| February 28, 2020 | 6 selling | +1.3% | −19.4% | −20.8% |
| May 31, 2019 | 3 selling | +9.5% | −0.7% | +11.8% |